Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That M

The treatment combines an mRNA shot with Merck's Keytruda.

CryptoAlerta — análise de criptomoedas e mercado em tempo real